Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C11H23NO4 |
| Molecular Weight | 233.3046 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@@H]1CO
InChI
InChIKey=HCZQIIVHWYFIPW-UKKRHICBSA-N
InChI=1S/C11H23NO4/c1-2-3-4-5-12-6-9(14)11(16)10(15)8(12)7-13/h8-11,13-16H,2-7H2,1H3/t8-,9-,10+,11+/m0/s1
| Molecular Formula | C11H23NO4 |
| Molecular Weight | 233.3046 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:06:19 GMT 2023
by
admin
on
Fri Dec 15 16:06:19 GMT 2023
|
| Record UNII |
T5Y7NB5M2U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
701719
Created by
admin on Fri Dec 15 16:06:19 GMT 2023 , Edited by admin on Fri Dec 15 16:06:19 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
441061-33-2
Created by
admin on Fri Dec 15 16:06:19 GMT 2023 , Edited by admin on Fri Dec 15 16:06:19 GMT 2023
|
PRIMARY | |||
|
C174914
Created by
admin on Fri Dec 15 16:06:19 GMT 2023 , Edited by admin on Fri Dec 15 16:06:19 GMT 2023
|
PRIMARY | |||
|
11096
Created by
admin on Fri Dec 15 16:06:19 GMT 2023 , Edited by admin on Fri Dec 15 16:06:19 GMT 2023
|
PRIMARY | |||
|
100000183715
Created by
admin on Fri Dec 15 16:06:19 GMT 2023 , Edited by admin on Fri Dec 15 16:06:19 GMT 2023
|
PRIMARY | |||
|
9859470
Created by
admin on Fri Dec 15 16:06:19 GMT 2023 , Edited by admin on Fri Dec 15 16:06:19 GMT 2023
|
PRIMARY | |||
|
T5Y7NB5M2U
Created by
admin on Fri Dec 15 16:06:19 GMT 2023 , Edited by admin on Fri Dec 15 16:06:19 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR |
50 fold more potent an inhibitor to GBA2 than to GCS.
|
||
|
|
TARGET -> INHIBITOR |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
